articleTop 1% cited

Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies

Journal of the American Academy of Dermatology · 2008 · Vol. 59(4) · pp. 596–601

J. Revuz✉(Assistance Publique – Hôpitaux de Paris)Florence Canouï‐Poitrine(Santé Publique France)P. Wolkenstein(Assistance Publique – Hôpitaux de Paris)C. VialletteG. Gabison(Assistance Publique – Hôpitaux de Paris)F. Pouget(Hôpital Albert-Chenevier)F. Poli(Assistance Publique – Hôpitaux de Paris)Ousmane Faye(Institut du Sahel)Jean Claude Roujeau(Université Paris-Est Créteil)G. Bonnélye(Kantar TNS (France))Jean‐Jacques Grob(Hôpital Sainte-Marguerite)Sylvie Bastuji‐Garin(Santé Publique France)

View via DOI Publisher page

Hidradenitis Suppurativa and Treatments Colorectal and Anal Carcinomas Anorectal Disease Treatments and OutcomesHidradenitis suppurativaMedicineOdds ratioEpidemiologyPopulationCase-control studyConfidence intervalBody mass indexCross-sectional studyInternal medicine

MeSH terms

AdultAlcohol DrinkingFemaleFranceHumansMaleObesityRisk FactorsSmokingComorbidityCausalityPrevalenceMultivariate AnalysisOdds RatioCase-Control Studies

Citations

615

FWCI

21.42

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β